Literature DB >> 30560044

First Impressions-the Potential of Altering Initial Host-Virus Interactions for Rational Design of Herpesvirus Vaccine Vectors.

Paul J F Rider1, Farhana Musarrat1, Rafiq Nabil1, Shan Naidu1, Konstantin G Kousoulas1.   

Abstract

PURPOSE: The earliest host-virus interactions occur during virus attachment and entry into cells. These initial steps in the virus lifecycle influence the outcome of infection beyond delivery of the viral genome into the cell. Herpesviruses alter host signaling pathways and processes during attachment and entry to facilitate virus infection and modulate innate immune responses. We suggest in this review that understanding these early signaling events may inform the rational design of therapeutic and prevention strategies for herpesvirus infection, as well as the engineering of viral vectors for immunotherapy purposes. RECENT
FINDINGS: Recent reports demonstrate that modulation of Herpes Simplex Virus Type-1 (HSV-1) entry results in unexpected enhancement of antiviral immune responses.
SUMMARY: A variety of evidence suggests that herpesviruses promote specific cellular signaling responses that facilitate viral replication after binding to cell surfaces, as well as during virus entry. Of particular interest is the ability of the virus to alter innate immune responses through these cellular signaling events. Uncovering the underlying immune evasion strategies may lead to the design of live-attenuated vaccines that can generate robust and protective anti-viral immune responses against herpesviruses. These adjuvant properties may be extended to a variety of heterologous antigens expressed by herpesviral vectors.

Entities:  

Keywords:  HSV; VC2; Vaccine; gK; herpesvirus; herpesvirus vector

Year:  2018        PMID: 30560044      PMCID: PMC6294296          DOI: 10.1007/s40588-018-0082-1

Source DB:  PubMed          Journal:  Curr Clin Microbiol Rep        ISSN: 2196-5471


  130 in total

1.  FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells.

Authors:  N Fournier; L Chalus; I Durand; E Garcia; J J Pin; T Churakova; S Patel; C Zlot; D Gorman; S Zurawski; J Abrams; E E Bates; P Garrone
Journal:  J Immunol       Date:  2000-08-01       Impact factor: 5.422

Review 2.  Two Epstein-Barr virus glycoprotein complexes.

Authors:  L M Hutt-Fletcher; C M Lake
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

3.  Herpes simplex virus glycoprotein D bound to the human receptor HveA.

Authors:  A Carfí; S H Willis; J C Whitbeck; C Krummenacher; G H Cohen; R J Eisenberg; D C Wiley
Journal:  Mol Cell       Date:  2001-07       Impact factor: 17.970

4.  Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus.

Authors:  Corina M Borza; Lindsey M Hutt-Fletcher
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

5.  Engineered herpes simplex virus 1 is dependent on IL13Ralpha 2 receptor for cell entry and independent of glycoprotein D receptor interaction.

Authors:  Guoying Zhou; Guo-Jie Ye; Waldemar Debinski; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

6.  A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry.

Authors:  D Shukla; J Liu; P Blaiklock; N W Shworak; X Bai; J D Esko; G H Cohen; R J Eisenberg; R D Rosenberg; P G Spear
Journal:  Cell       Date:  1999-10-01       Impact factor: 41.582

7.  Protection by herpes simplex virus glycoprotein D against Fas-mediated apoptosis: role of nuclear factor kappaB.

Authors:  M Antonietta Medici; M Teresa Sciortino; Donata Perri; Carla Amici; Elisa Avitabile; Marco Ciotti; Emanuela Balestrieri; Enrico De Smaele; Guido Franzoso; Antonio Mastino
Journal:  J Biol Chem       Date:  2003-07-04       Impact factor: 5.157

8.  Identification and characterization of a novel herpes simplex virus glycoprotein, gK, involved in cell fusion.

Authors:  L Hutchinson; K Goldsmith; D Snoddy; H Ghosh; F L Graham; D C Johnson
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

9.  Functional profiling of a human cytomegalovirus genome.

Authors:  Walter Dunn; Cassie Chou; Hong Li; Rong Hai; David Patterson; Viktor Stolc; Hua Zhu; Fenyong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

10.  Herpes simplex virus triggers activation of calcium-signaling pathways.

Authors:  Natalia Cheshenko; Brian Del Rosario; Craig Woda; Daniel Marcellino; Lisa M Satlin; Betsy C Herold
Journal:  J Cell Biol       Date:  2003-10-20       Impact factor: 10.539

View more
  1 in total

1.  Intramuscular vaccination of mice with the human herpes simplex virus type-1(HSV-1) VC2 vaccine, but not its parental strain HSV-1(F) confers full protection against lethal ocular HSV-1 (McKrae) pathogenesis.

Authors:  Shan K Naidu; Rafiq Nabi; Nagarjuna R Cheemarla; Brent A Stanfield; Paul J Rider; Nithya Jambunathan; Vladimir N Chouljenko; Renee Carter; Fabio Del Piero; Ingeborg Langohr; Konstantin G Kousoulas
Journal:  PLoS One       Date:  2020-02-06       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.